Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6401065 | 0.83 | CHRNA1 (0.39) | ALDH1A1HSD11B1DRD2CHRNB2SLC6A2 | |
| SCHEMBL6400054 | 0.80 | CHRNA1 (0.40) | ALDH1A1HSD11B1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7983386 | 0.75 | ALDH1A1 (0.40) | ALDH1A1CYP1A2HCAR3HCAR2CYP2C9 | |
| SCHEMBL4258794 | 0.70 | CFTR (0.45) | ALDH1A1HCAR3HCAR2CYP2C9CYP2C19 | |
| SCHEMBL5857767 | 0.67 | MMP2 (0.41) | ALDH1A1CYP1A2HCAR3HCAR2CYP2C9 | |
| SCHEMBL8149296 | 0.66 | CYP1A2 (0.39) | ALDH1A1CYP1A2HCAR3HCAR2HSD11B1 | |
| SCHEMBL10641405 | 0.66 | CYP1A2 (0.39) | ALDH1A1CYP1A2HCAR3HCAR2MMP2 | |
| SCHEMBL10641415 | 0.66 | CYP1A2 (0.39) | ALDH1A1CYP1A2HCAR3HCAR2MMP2 | |
| SCHEMBL10641412 | 0.66 | CYP1A2 (0.39) | ALDH1A1CYP1A2HCAR3HCAR2MMP2 | |
| SCHEMBL3291202 | 0.66 | SIRT1 (0.46) | ALDH1A1CYP1A2HCAR3HCAR2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1583967-B1 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | AICURIS GMBH & CO KG (DE) | 2007-06-27 | — | — | EP | disclosed |
| EP-1583967-B1 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | AICURIS GMBH & CO KG (DE) | 2007-06-27 | — | — | EP | disclosed |
| US-20070004735-A1 | Method for inhibiting the replication of herpes viruses | AICURIS GMBH & CO. KG (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004735-A1 | Method for inhibiting the replication of herpes viruses | AICURIS GMBH & CO. KG (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004735-A1 | Method for inhibiting the replication of herpes viruses | AICURIS GMBH & CO. KG (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1583967-A2 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | Bayer HealthCare AG (DE) | 2005-10-12 | — | — | EP | disclosed |
| US-20050059658-A1 | Pyridazinone | BAYER AKTIENGESELLSCHAFT (DE) | 2005-03-17 | — | — | US | disclosed |
| WO-2004060860-A2 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | BAYER HEALTHCARE AG (DE) | 2004-07-22 | — | — | WO | disclosed |
| EP-1404657-A1 | PYRIDAZINONE | Bayer HealthCare AG (DE) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003002541-A1 | PYRIDAZINONE | BAYER HEALTHCARE AG (DE) | 2003-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059658-A1 | Pyridazinone | TYMP, TPMT, PDXK | ALDH1A1 3281/4885CYP1A2 1273/4885HCAR3 1959/4885 |
| US-20070004735-A1 | Method for inhibiting the replication of herpes viruses | RPL35, PCNA, MCM5 | ALDH1A1 4193/4885CYP1A2 4625/4885HCAR3 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.